These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 32430642)

  • 1. Value of quantitative multiparametric MRI in differentiating pleomorphic adenomas from malignant epithelial tumors in lacrimal gland.
    Wang Y; Song L; Guo J; Xian J
    Neuroradiology; 2020 Sep; 62(9):1141-1147. PubMed ID: 32430642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.
    Wu YC; Xiao ZB; Lin XH; Zheng XY; Cao DR; Zhang ZS
    World J Gastroenterol; 2020 Oct; 26(39):6057-6073. PubMed ID: 33132655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 4. Multiparametric approach with diffusion-weighted imaging and dynamic contrast-enhanced MRI: a comparison study for differentiating between benign and malignant bone lesions in adults.
    Oh E; Yoon YC; Kim JH; Kim K
    Clin Radiol; 2017 Jul; 72(7):552-559. PubMed ID: 28325514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of diffusion kurtosis imaging and quantitative dynamic contrast-enhanced MRI for the differentiation of breast tumors.
    Li T; Yu T; Li L; Lu L; Zhuo Y; Lian J; Xiong Y; Kong D; Li K
    J Magn Reson Imaging; 2018 Nov; 48(5):1358-1366. PubMed ID: 29717790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors.
    Lee SK; Jee WH; Jung CK; Chung YG
    Br J Radiol; 2020 Nov; 93(1115):20191035. PubMed ID: 32649224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation between orbital malignant and benign tumors using intravoxel incoherent motion diffusion-weighted imaging: Correlation with dynamic contrast-enhanced magnetic resonance imaging.
    Xu XQ; Hu H; Su GY; Liu H; Wu FY; Shi HB
    Medicine (Baltimore); 2019 Mar; 98(12):e14897. PubMed ID: 30896639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of diffusion-weighted (DWI) and dynamic contrast-enhanced (DCE) MRI for the differentiation of benign from malignant soft-tissue tumors.
    Choi YJ; Lee IS; Song YS; Kim JI; Choi KU; Song JW
    J Magn Reson Imaging; 2019 Sep; 50(3):798-809. PubMed ID: 30663160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histogram Analysis Comparison of Monoexponential, Advanced Diffusion-Weighted Imaging, and Dynamic Contrast-Enhanced MRI for Differentiating Borderline From Malignant Epithelial Ovarian Tumors.
    He M; Song Y; Li H; Lu J; Li Y; Duan S; Qiang J
    J Magn Reson Imaging; 2020 Jul; 52(1):257-268. PubMed ID: 31922327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative dynamic contrast-enhanced MRI and readout segmentation of long variable echo-trains diffusion-weighted imaging in differentiating parotid gland tumors.
    Huang N; Xiao Z; Chen Y; She D; Guo W; Yang X; Chen Q; Cao D; Chen T
    Neuroradiology; 2021 Oct; 63(10):1709-1719. PubMed ID: 34241661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of DCE-MRI and DWI in the differential diagnosis of inflammatory pseudotumor and lymphoma in the lacrimal gland].
    Feng LL; Xian JF; Yan F; Fu L; Zhou HY
    Zhonghua Yi Xue Za Zhi; 2017 Feb; 97(7):487-491. PubMed ID: 28260285
    [No Abstract]   [Full Text] [Related]  

  • 14. Glioma grading capability: comparisons among parameters from dynamic contrast-enhanced MRI and ADC value on DWI.
    Choi HS; Kim AH; Ahn SS; Shin NY; Kim J; Lee SK
    Korean J Radiol; 2013; 14(3):487-92. PubMed ID: 23690718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.
    Guo P; Liu Z; Yan F; Wang J; Wei L; Lv H; Wang Z; Xian J
    Acta Radiol; 2016 Dec; 57(12):1490-1496. PubMed ID: 27012277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of monoexponential diffusion-weighted imaging and diffusion kurtosis imaging and dynamic contrast-enhanced-MRI for the differentiation of spinal tumors.
    Zhang J; Chen Y; Zhang E; Li N; Yuan H; Lang N
    Eur Spine J; 2020 May; 29(5):1112-1120. PubMed ID: 32040617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application evaluation of DCE-MRI combined with quantitative analysis of DWI for the diagnosis of prostate cancer.
    Ma XZ; Lv K; Sheng JL; Yu YX; Pang PP; Xu MS; Wang SW
    Oncol Lett; 2019 Mar; 17(3):3077-3084. PubMed ID: 30867737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential diagnosis of parotid gland tumours: Application of SWI combined with DWI and DCE-MRI.
    Xu Z; Chen M; Zheng S; Chen S; Xiao J; Hu Z; Lu L; Yang Z; Lin D
    Eur J Radiol; 2022 Jan; 146():110094. PubMed ID: 34906852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of the apparent diffusion coefficient in diffusion weighted imaging at 3.0T MR for differentiating lacrimal gland tumors].
    Wang YZ; Xian JF; Yang BT; Guo J; Wang XY; Song LY
    Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):53-56. PubMed ID: 30641666
    [No Abstract]   [Full Text] [Related]  

  • 20. Differentiation of various salivary gland tumours using diffusion-weighted MRI and dynamic contrast-enhanced MRI.
    Kushwaha M; Kumar J; Garg A; Singh I; Khurana N
    Pol J Radiol; 2023; 88():e203-e215. PubMed ID: 37234459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.